Savitz Adam

CHIEF MEDICAL OFFICERAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Jul 8, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 3, 2025Disposed to issuer(D)76K0
Jul 3, 2025Grant(A)76K76K
Jul 3, 2025Disposed to issuer(D)73K0
Jul 3, 2025Grant(A)73K73K
Jul 3, 2025Disposed to issuer(D)124K0
Jul 3, 2025Grant(A)124K124K
Jul 3, 2025Disposed to issuer(D)33K0
Jul 3, 2025Grant(A)33K33K
Jul 3, 2025Disposed to issuer(D)22K0
Jul 3, 2025Grant(A)22K22K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999480-25-000064) within minutes of acceptance. Every field above traces to the original document. Verify it directly: